FDA Inspection 775226 — Akers Biosciences, Inc.

Akers Biosciences, Inc. — FEI 1000121922

The FDA completed an inspection of Akers Biosciences, Inc. on Apr 11, 2012 in Thorofare, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 11, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Compliance: Devices
Location
Thorofare, NJ (United States)

Citations

IDCFRDescription
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.